缺血性卒中血栓DNA含量有助于识别不明原因卒中的心源性栓塞
该研究对250例急性缺血性卒中患者的血栓匀浆进行定量生化检测,分析血栓细胞组成与卒中病因(TOAST分型)的相关性。结果显示心源性栓塞血栓DNA含量显著高于非心源性栓塞(35.8 vs 13.8 ng/mg,P<0.001),DNA鉴别心源性栓塞的AUC为0.72(95%CI 0.63-0.81);以44.7 ng/mg为阈值,47%的不明原因血栓可归类为心源性栓塞,特异性90%。结论提示血栓DNA含量可能作为识别不明原因栓塞性卒中中心源性栓塞的准确生物标志物。
要点
- 心源性栓塞血栓DNA含量显著高于非心源性栓塞(35.8 vs 13.8 ng/mg,P<0.001)。
- DNA鉴别心源性栓塞的AUC为0.72(95%CI 0.63-0.81)。
- 阈值44.7 ng/mg可将47%的不明原因血栓归类为心源性栓塞,特异性90%。
核心结论
- 血栓DNA含量可能作为识别不明原因栓塞性卒中患者中心源性栓塞的准确生物标志物。
研究设计与样本
- 对250例急性缺血性卒中患者的血栓匀浆进行定量生化检测,按TOAST分型定义病因为心源性栓塞、非心源性栓塞或不明原因栓塞性卒中。
主要发现
- 心源性栓塞血栓DNA含量高于非心源性栓塞(35.8 vs 13.8 ng/mg,P<0.001)。
- 心源性栓塞血栓GPVI含量低于非心源性栓塞(0.104 vs 0.117 ng/mg,P=0.045)。
- DNA含量鉴别心源性栓塞与非心源性栓塞的AUC为0.72(95%CI 0.63-0.81)。
关键数值与推荐
- 以44.7 ng DNA/mg血栓为阈值,47%的不明原因血栓可归类为心源性栓塞,特异性90%。
临床怎么用
- 对于不明原因栓塞性卒中患者,检测血栓DNA含量可能辅助识别心源性栓塞,指导二级预防。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Identification of acute ischemic stroke (AIS) cause is crucial for guidance of secondary prevention. Previous studies have yielded inconsistent results regarding possible correlations between AIS cause and thrombus composition, as assessed by semiquantitative histological analysis. Here, we performed a correlation analysis between AIS cause and AIS thrombus cellular composition and content, as assessed using quantitative biochemical assays. METHODS: Homogenates of 250 patients with AIS thrombi were prepared by mechanical grinding. Platelet, red blood cell, and leukocyte content of AIS thrombi were estimated by quantification of GP (glycoprotein) VI, heme, and DNA in thrombus homogenates. AIS cause was defined as cardioembolic, noncardioembolic, or embolic stroke of undetermined source, according to the TOAST classification (Trial of ORG 10172 in Acute Stroke Treatment). RESULTS: Cardioembolic thrombi were richer in DNA (35.8 versus 13.8 ng/mg, P<0.001) and poorer in GPVI (0.104 versus 0.117 ng/mg, P=0.045) than noncardioembolic ones. The area under the receiver operating characteristic curve of DNA content to discriminate cardioembolic thrombi from noncardioembolic was 0.72 (95% CI, 0.63-0.81). With a threshold of 44.7 ng DNA/mg thrombus, 47% of thrombi from undetermined cause would be classified as cardioembolic with a specificity of 90%. CONCLUSIONS: Thrombus DNA content may provide an accurate biomarker for identification of cardioembolic thrombi in patients with AIS with embolic stroke of undetermined source. Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT03268668.
引用
- Di Meglio L, Desilles JP, Solonomenjanahary M, et al. DNA Content in Ischemic Stroke Thrombi Can Help Identify Cardioembolic Strokes Among Strokes of Undetermined Cause. Stroke. 2020. PMID: 32811390. doi:10.1161/STROKEAHA.120.029134
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。